Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease

Renal Failure

Volumn 30, Issue 6, 2008, Pages 625-628

  Malyszko, Jolanta ^a   Bachorzewska Gajewska, Hanna ^a   Sitniewska, Ewa ^a   Malyszko, Jacek S ^a   Poniatowski, Boguslaw ^a   Dobrzycki, Slawomir ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Chronic kidney disease; Cystatin C; GFR; Kidney function; NGAL

Indexed keywords

CREATININE; CYSTATIN C; EPIDERMAL GROWTH FACTOR; HEMOGLOBIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CREATININE; CYSTATINS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 48149112968     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802134607     Document Type: Article

References (13)

1. National Kidney Foundation. K/DOQI: Clinical Practice Guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39: S1-S266.
2. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. NGAL (neutrophil gelatinase-associated lipocalin) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronarography. Nephrol Dial Transplant. 2007;22:295-296.
3. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant. 2006;21:1855-1862.
4. Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22:101-108.
5. Modification of Diet in Renal Disease Study Group. Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int. 1989;36:S73-S80.
6. Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J Am Soc Nephrol. 2005;16:2449-2455.
7. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68:237-245.
8. Panichi V, Migliori M, De Pietro S, et al. C-reactive protein in patients with chronic renal diseases. Ren Fail. 2001;23:551-562.
9. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, et al. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens. 2006;15:442-449.
10. Aström-Olsson K, Hedström E, Hultén LM, et al. Dissociation of the inflammatory reaction following PCI for acute myocardial infarction. J Invasive Cardiol. 2007;19:452-456.
11. Paulsson J, Dadfar E, Held C, Jacobson SH, Lundahl J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis. 2007;192:328-334.
12. Ding H, He Y, Li K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007;123:227-234.
13. Bolignano D, Coppolino G, Campo S, et al. Neutrophil gelatinase- associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373-378.